Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Combination Chemotherapy and Radiation of Human Squamous Cell Carcinoma of the Head and Neck Augments CTL-Mediated Lysis

Clin Cancer Res (2006) 12 (6): 1897–1905.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
Chemotherapy and Physical Therapeutics Modulate Antigens on Cancer Cells
  • Wojciech Szlasa
  • Natalia Janicka
  • Natalia Sauer
  • Olga Michel
  • Bernadetta Nowak
  • Jolanta Saczko
  • Julita Kulbacka
Frontiers in Immunology (2022) 13
Impact of Systemic Autoimmune Diseases on Treatment Outcomes and Radiation Toxicities in Patients with Stage I Non-Small Cell Lung Cancer Receiving Stereotactic Body Radiation Therapy: A Matched Case-Control Analysis
  • Zhe Chen
  • Hotaka Nonaka
  • Hiroshi Onishi
  • Eiji Nakatani
  • Mitsuhiko Oguri
  • Masahide Saito
  • Shinichi Aoki
  • Kan Marino
  • Takafumi Komiyama
  • Kengo Kuriyama
  • Masayuki Araya
  • Licht Tominaga
  • Ryo Saito
  • Yoshiyasu Maehata
  • Ryoji Shinohara
Cancers (2022) 14 (23): 5915.
PARP inhibitor Olaparib Enhances the Apoptotic Potentiality of Curcumin by Increasing the DNA Damage in Oral Cancer Cells through Inhibition of BER Cascade
  • Sefinew Molla
  • Krushna Chandra Hembram
  • Subhajit Chatterjee
  • Deepika Nayak
  • Chinmayee Sethy
  • Rajalaxmi Pradhan
  • Chanakya Nath Kundu
Pathology & Oncology Research (2020) 26 (4): 2091.
Peripheral Cytokine Levels Differ by HPV Status and Change Treatment-Dependently in Patients with Head and Neck Squamous Cell Carcinoma
  • Daphne Mytilineos
  • Jasmin Ezić
  • Adrian von Witzleben
  • Joannis Mytilineos
  • Ramin Lotfi
  • Daniel Fürst
  • Chrysanthi Tsamadou
  • Marie-Nicole Theodoraki
  • Angelika Oster
  • Gunnar Völkel
  • Hans A. Kestler
  • Cornelia Brunner
  • Patrick J. Schuler
  • Johannes Doescher
  • Thomas K. Hoffmann
  • Simon Laban
International Journal of Molecular Sciences (2020) 21 (17): 5990.
Efficacy and Safety of Antigen-specific Immunotherapy in the Treatment of Patients with Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis
  • Bing-Di Yan
  • Xiao-Feng Cong
  • Sha-Sha Zhao
  • Meng Ren
  • Zi-Ling Liu
  • Zhi Li
  • Chen Chen
  • Lei Yang
Current Cancer Drug Targets (2019) 19 (3): 199.
Role of immunotherapy in stage III nonsmall cell lung cancer
  • Anna Wrona
Current Opinion in Oncology (2019) 31 (1): 18.
Metal Drugs and the Anticancer Immune Response
  • Bernhard Englinger
  • Christine Pirker
  • Petra Heffeter
  • Alessio Terenzi
  • Christian R. Kowol
  • Bernhard K. Keppler
  • Walter Berger
Chemical Reviews (2019) 119 (2): 1519.
Immunological consequences of chemotherapy: Single drugs, combination therapies and nanoparticle-based treatments
  • Anusha Pusuluri
  • Debra Wu
  • Samir Mitragotri
Journal of Controlled Release (2019) 305: 130.
Role of the tumor microenvironment in pancreatic cancer
  • Takashi Murakami
  • Yukihiko Hiroshima
  • Ryusei Matsuyama
  • Yuki Homma
  • Robert M. Hoffman
  • Itaru Endo
Annals of Gastroenterological Surgery (2019) 3 (2): 130.
Current perspectives on bone metastases in castrate-resistant prostate cancer
  • Christopher Logothetis
  • Michael J. Morris
  • Robert Den
  • Robert E. Coleman
Cancer and Metastasis Reviews (2018) 37 (1): 189.
Immune Responses to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer
  • Amir Sherif
  • Malin Winerdal
  • Ola Winqvist
Bladder Cancer (2018) 4 (1): 1.
Immunological monitoring for prediction of clinical response to antitumor vaccine therapy
  • Irina N. Mikhaylova
  • Irina Zh. Shubina
  • George Z. Chkadua
  • Natalia N. Petenko
  • Lidia F. Morozova
  • Olga S. Burova
  • Robert Sh. Beabelashvili
  • Kermen A. Parsunkova
  • Natalia V. Balatskaya
  • Dmitrii K. Chebanov
  • Vadim I. Pospelov
  • Valeria V. Nazarova
  • Anastasia S. Vihrova
  • Evgeny A. Cheremushkin
  • Alvina A. Molodyk
  • Mikhail V. Kiselevsky
  • Lev V. Demidov
Oncotarget (2018) 9 (36): 24381.
Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting
  • Julie E. Bauman
  • Ezra Cohen
  • Robert L. Ferris
  • David J. Adelstein
  • David M. Brizel
  • John A. Ridge
  • Brian O'Sullivan
  • Barbara A. Burtness
  • Lisa H. Butterfield
  • William E. Carson
  • Mary L. Disis
  • Bernard A. Fox
  • Thomas F. Gajewski
  • Maura L. Gillison
  • James W. Hodge
  • Quynh-Thu Le
  • David Raben
  • Scott E. Strome
  • Jean Lynn
  • Shakun Malik
Cancer (2017) 123 (7): 1259.
Cytotoxic T lymphocytes promote cytarabine-induced acute myeloid leukemia cell apoptosis via inhibiting Bcl-2 expression
  • Rui Deng
  • Fang-Yi Fan
  • Hai Yi
  • Li Fu
  • Yan Zeng
  • Yi Wang
  • Xiao-Juan Miao
  • Yan-Rong Shuai
  • Guang-Cui He
  • Yi Su
Experimental and Therapeutic Medicine (2017) 14 (2): 1081.
Meeting Report From the Prostate Cancer Foundation Scientific Working Group on Radium-223
  • Andrea K. Miyahira
  • Michael Morris
  • Howard R. Soule
The Prostate (2017) 77 (3): 245.
Ectopic overexpression of CD133 in HNSCC makes it resistant to commonly used chemotherapeutics
  • Junyoung Lee
  • Mineon Park
  • Youngjong Ko
  • Bora Kim
  • Okjoon Kim
  • Hoon Hyun
  • DongHwi Kim
  • HongMoon Sohn
  • Young Lae Moon
  • Wonbong Lim
Tumor Biology (2017) 39 (4): 101042831769553.
Neoadjuvant chemoradiotherapy of pancreatic cancer induces a favorable immunogenic tumor microenvironment associated with increased major histocompatibility complex class I-related chain A/B expression
  • Takashi Murakami
  • Yuki Homma
  • Ryusei Matsuyama
  • Ryutaro Mori
  • Kentaro Miyake
  • Yusaku Tanaka
  • Kanechika Den
  • Yoji Nagashima
  • Masatoshi Nakazawa
  • Yukihiko Hiroshima
  • Michio Ueda
  • Kuniya Tanaka
  • Robert M. Hoffman
  • Michael Bouvet
  • Itaru Endo
Journal of Surgical Oncology (2017) 116 (3): 416.
Identification and characterization of enhancer agonist human cytotoxic T-cell epitopes of the human papillomavirus type 16 (HPV16) E6/E7
  • Kwong Y. Tsang
  • Massimo Fantini
  • Romaine I. Fernando
  • Claudia Palena
  • Justin M. David
  • James W. Hodge
  • Elizabeth S. Gabitzsch
  • Frank R. Jones
  • Jeffrey Schlom
Vaccine (2017) 35 (19): 2605.
Dose-dependent enhancement of T-lymphocyte priming and CTL lysis following ionizing radiation in an engineered model of oral cancer
  • Megan Morisada
  • Ellen C. Moore
  • Rachel Hodge
  • Jay Friedman
  • Harrison A. Cash
  • James W. Hodge
  • James B. Mitchell
  • Clint T. Allen
Oral Oncology (2017) 71: 87.
Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma
  • Linda Tran
  • Clint T. Allen
  • Roy Xiao
  • Ellen Moore
  • Ruth Davis
  • So-Jin Park
  • Katie Spielbauer
  • Carter Van Waes
  • Nicole C. Schmitt
Cancer Immunology Research (2017) 5 (12): 1141.
The rationale for including immune checkpoint inhibition into multimodal primary treatment concepts of head and neck cancer
  • Ingeborg Tinhofer
  • Volker Budach
  • Korinna Jöhrens
  • Ulrich Keilholz
Cancers of the Head & Neck (2016) 1 (1)
Immuno-oncology: Allying forces of radio- and immuno-therapy to enhance cancer cell killing
  • Jacques Bernier
Critical Reviews in Oncology/Hematology (2016) 108: 97.
Immunomodulatory effects of radiation: what is next for cancer therapy?
  • Anita Kumari
  • Samantha S Simon
  • Tomika D Moody
  • Charlie Garnett-Benson
Future Oncology (2016) 12 (2): 239.
Effector function of CTLs is increased by irradiated colorectal tumor cells that modulate OX-40L and 4-1BBL and is reversed following dual blockade
  • Anita Kumari
  • Charlie Garnett-Benson
BMC Research Notes (2016) 9 (1)
Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell–Mediated Killing
  • Sofia R. Gameiro
  • Anthony S. Malamas
  • Michael B. Bernstein
  • Kwong Y. Tsang
  • April Vassantachart
  • Narayan Sahoo
  • Ramesh Tailor
  • Rajesh Pidikiti
  • Chandan P. Guha
  • Stephen M. Hahn
  • Sunil Krishnan
  • James W. Hodge
International Journal of Radiation Oncology*Biology*Physics (2016) 95 (1): 120.
Interleukin-15: New kid on the block for antitumor combination therapy
  • Johan M.J. Van den Bergh
  • Viggo F.I. Van Tendeloo
  • Evelien L.J.M. Smits
Cytokine & Growth Factor Reviews (2015) 26 (1): 15.
Attenuated mutant strain of Salmonella Typhimurium lacking the ZnuABC transporter contrasts tumor growth promoting anti-cancer immune response
  • Barbara Chirullo
  • Serena Ammendola
  • Leonardo Leonardi
  • Roberto Falcini
  • Paola Petrucci
  • Claudia Pistoia
  • Silvia Vendetti
  • Andrea Battistoni
  • Paolo Pasquali
Oncotarget (2015) 6 (19): 17648.
Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer
  • Jean-Louis Pujol
  • Johan F. Vansteenkiste
  • Tommaso Martino De Pas
  • Djordje Atanackovic
  • Martin Reck
  • Michiel Thomeer
  • Jean-Yves Douillard
  • Gianpiero Fasola
  • Vanessa Potter
  • Paul Taylor
  • Lionel Bosquée
  • Robert Scheubel
  • Silvija Jarnjak
  • Muriel Debois
  • Pedro de Sousa Alves
  • Jamila Louahed
  • Vincent G. Brichard
  • Frédéric F. Lehmann
Journal of Thoracic Oncology (2015) 10 (10): 1458.
Immunotherapeutic Agents in Non-small-cell Lung Cancer Finally Coming to the Front Lines
  • Rossana Ruiz
  • Brian Hunis
  • Luis E. Raez
Current Oncology Reports (2014) 16 (9)
Radiation-Induced Modulation of Costimulatory and Coinhibitory T-Cell Signaling Molecules on Human Prostate Carcinoma Cells Promotes Productive Antitumor Immune Interactions
  • Michael B. Bernstein
  • Charlie T. Garnett
  • Huogang Zhang
  • Anna Velcich
  • Max M. Wattenberg
  • Sofia R. Gameiro
  • Shalom Kalnicki
  • James W. Hodge
  • Chandan Guha
Cancer Biotherapy and Radiopharmaceuticals (2014) 29 (4): 153.
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial
  • Charles Butts
  • Mark A Socinski
  • Paul L Mitchell
  • Nick Thatcher
  • Libor Havel
  • Maciej Krzakowski
  • Sergiusz Nawrocki
  • Tudor-Eliade Ciuleanu
  • Lionel Bosquée
  • José Manuel Trigo
  • Alexander Spira
  • Lise Tremblay
  • Jan Nyman
  • Rodryg Ramlau
  • Gun Wickart-Johansson
  • Peter Ellis
  • Oleg Gladkov
  • José Rodrigues Pereira
  • Wilfried Ernst Erich Eberhardt
  • Christoph Helwig
  • Andreas Schröder
  • Frances A Shepherd
The Lancet Oncology (2014) 15 (1): 59.
Expanding the use of monoclonal antibody therapy of cancer by using ionising radiation to upregulate antibody targets
  • M M Wattenberg
  • A R Kwilas
  • S R Gameiro
  • A P Dicker
  • J W Hodge
British Journal of Cancer (2014) 110 (6): 1472.
Cisplatin-Induced Antitumor Immunomodulation: A Review of Preclinical and Clinical Evidence
  • Andreas R. de Biasi
  • Jonathan Villena-Vargas
  • Prasad S. Adusumilli
Clinical Cancer Research (2014) 20 (21): 5384.
Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8+ T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma model
  • Christian Bauer
  • Alexander Sterzik
  • Franz Bauernfeind
  • Peter Duewell
  • Claudius Conrad
  • Rosemarie Kiefl
  • Stefan Endres
  • Andreas Eigler
  • Max Schnurr
  • Marc Dauer
Cancer Immunology, Immunotherapy (2014) 63 (4): 321.
Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing
  • Sofia R. Gameiro
  • Momodou L. Jammeh
  • Max M. Wattenberg
  • Kwong Y. Tsang
  • Soldano Ferrone
  • James W. Hodge
Oncotarget (2014) 5 (2): 403.
Androgen deprivation therapy sensitizes prostate cancer cells to T-cell killing through androgen receptor dependent modulation of the apoptotic pathway
  • Andressa Ardiani
  • Sofia R. Gameiro
  • Anna R. Kwilas
  • Renee N. Donahue
  • James W. Hodge
Oncotarget (2014) 5 (19): 9335.
Identification of a novel HLA-A*02:01-restricted cytotoxic T lymphocyte epitope derived from the EML4-ALK fusion gene
  • MAYUKO YOSHIMURA
  • YOSHITAKA TADA
  • KAZUYA OFUZI
  • MASAKAZU YAMAMOTO
  • TETSUYA NAKATSURA
Oncology Reports (2014) 32 (1): 33.
Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
  • Silvia C. Formenti
  • Sandra Demaria
JNCI: Journal of the National Cancer Institute (2013) 105 (4): 256.
Turning T cells on: epigenetically enhanced expression of effector T-cell costimulatory molecules on irradiated human tumor cells
  • Anita Kumari
  • Ercan Cacan
  • Susanna F Greer
  • Charlie Garnett-Benson
Journal for ImmunoTherapy of Cancer (2013) 1 (1): 17.
Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death
  • James W. Hodge
  • Charlie T. Garnett
  • Benedetto Farsaci
  • Claudia Palena
  • Kwong-Yok Tsang
  • Soldano Ferrone
  • Sofia R. Gameiro
International Journal of Cancer (2013) 133 (3): 624.
Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials
  • Nishith Singh
  • Ravi Madan
  • James L Gulley
Clinical Investigation (2013) 3 (7): 651.
Decreased HPV-specific T cell responses and accumulation of immunosuppressive influences in oropharyngeal cancer patients following radical therapy
  • Saly Al-Taei
  • Russell Banner
  • Ned Powell
  • Mererid Evans
  • Nachi Palaniappan
  • Zsuzsanna Tabi
  • Stephen Man
Cancer Immunology, Immunotherapy (2013) 62 (12): 1821.
Combination Therapy with Local Radiofrequency Ablation and Systemic Vaccine Enhances Antitumor Immunity and Mediates Local and Distal Tumor Regression
  • Sofia R. Gameiro
  • Jack P. Higgins
  • Matthew R. Dreher
  • David L. Woods
  • Goutham Reddy
  • Bradford J. Wood
  • Chandan Guha
  • James W. Hodge
  • Mauricio Martins Rodrigues
PLoS ONE (2013) 8 (7): e70417.
Harnessing the Potential of Radiation-Induced Immune Modulation for Cancer Therapy
  • Mansoor M. Ahmed
  • James W. Hodge
  • Chandan Guha
  • Eric J. Bernhard
  • Bhadrasain Vikram
  • C. Norman Coleman
Cancer Immunology Research (2013) 1 (5): 280.
Primary frontal sinus squamous cell carcinoma in three dogs treated with piroxicam combined with carboplatin or toceranib
  • J. de Vos
  • S. Ramos Vega
  • E. Noorman
  • P. de Vos
Veterinary and Comparative Oncology (2012) 10 (3): 206.
The clinical implications of antitumor immunity in head and neck cancer
  • Clint T. Allen
  • Nancy P. Judd
  • Jack D. Bui
  • Ravindra Uppaluri
The Laryngoscope (2012) 122 (1): 144.
Recent Advances in Therapeutic Cancer Vaccines
  • Jeffrey Schlom
Cancer Biotherapy and Radiopharmaceuticals (2012) 27 (1): 2.
Defining the Molecular Signature of Chemotherapy-Mediated Lung Tumor Phenotype Modulation and Increased Susceptibility to T-Cell Killing
  • Sofia R. Gameiro
  • Jorge A. Caballero
  • James W. Hodge
Cancer Biotherapy and Radiopharmaceuticals (2012) 27 (1): 23.
Clinical Evaluation of TRICOM Vector Therapeutic Cancer Vaccines
  • Ravi A. Madan
  • Marijo Bilusic
  • Christopher Heery
  • Jeffrey Schlom
  • James L. Gulley
Seminars in Oncology (2012) 39 (3): 296.
Sub-Lethal Irradiation of Human Colorectal Tumor Cells Imparts Enhanced and Sustained Susceptibility to Multiple Death Receptor Signaling Pathways
  • Victoria Ifeadi
  • Charlie Garnett-Benson
  • Gen Sheng Wu
PLoS ONE (2012) 7 (2): e31762.
  • Online ISSN 1557-3265
  • Print ISSN 1078-0432

AACR Journals

 

 

  • Copyright © 2022 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept